Technical Articles

BCL-XL/CRBN PROTAC试剂盒:推动肿瘤选择性蛋白降解疗法开发的标准化工具
BCL-XL/CRBN PROTAC Kit: A Standardized Tool for Advancing Tumor-Selective Protein Degradation Therapy Development
发布时间 2026-01-19
Proteolysis Targeting Chimeras (PROTAC) is a revolutionary drug development platform that harnesses the cell's own ubiquitin-proteasome system to selectively degrade disease-causing proteins.
View details
  • Cancer
  • BCL-XL/CRBN PROTAC Kit
  • Tumor
  • Protein degradation
基于BCL-XL/CRBN PROTAC试剂盒开发的新型BCL-XL降解剂增强BCL-2抑制功能的研究
Study on Novel BCL-XL Degraders Developed Based on BCL-XL/CRBN PROTAC Kits to Enhance BCL-2 Inhibitory Function
发布时间 2026-01-06
Evasion of apoptosis is a hallmark of cancer, often involving an imbalance between pro-apoptotic and anti-apoptotic proteins (such as BCL-2 family proteins).
View details
  • Cancer
  • BCL-XL/CRBN PROTAC Kit
  • Apoptosis evasion
  • Anti-apoptotic protein
Total 2
  • 1
Go to